Tag: epigenomics


  • Pioneering Personalized Medicine: Dr. Najaf Amin Redefines Depression Genetics with Multi-Omics

    Pioneering Personalized Medicine: Dr. Najaf Amin Redefines Depression Genetics with Multi-Omics

    Reframing Depression: From Neurotransmitters to a Systemic Disease In a groundbreaking Genomic Press interview published today, Dr. Najaf Amin, Oxford University Associate Professor and a towering figure in genetics, reveals a shift in how the global research community understands depression. Far from being viewed solely as a neurotransmitter imbalance, depression is increasingly seen as a…

  • Pioneering personalized medicine: deciphering depression’s complex biology

    Pioneering personalized medicine: deciphering depression’s complex biology

    Pioneering a systemic view of depression through multi-omics Depression has long been treated as a primarily brain-centric disorder, its causes sought in neurotransmitter imbalances and regional brain activity. A ground‑breaking Genomic Press interview with Dr. Najaf Amin, Oxford University Associate Professor and a leader in molecular epidemiology, shifts that narrative. Her team’s work spans genomics,…

  • Pioneering personalized medicine by deciphering depression’s complex biological web

    Pioneering personalized medicine by deciphering depression’s complex biological web

    Reframing depression through a systemic, multi-omics lens In a groundbreaking Genomic Press interview, Dr. Najaf Amin—Oxford University Associate Professor and a leading figure in molecular epidemiology—reveals how her research reshapes international understandings of depression genetics. Moving beyond traditional genome-wide association studies, she unveils a holistic approach that integrates genomics, epigenomics, metabolomics, and gut microbiome data…